Sensei Biotherapeutics
SNSE13.8500.00% ( 0.000 )
Sensei Biotherapeutics (SNSE)
Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 13.850
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- 36.760
- Volume Ratio
- 0.00
- Turnover Ratio
- --
Sensei Biotherapeutics Analyst Rating
View MoreForecast & Rating
Jun 5, 2026Price forecast
$51.67273.04%
Forecast & RatingStrong buy
4analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Jun 18 at 04:13 PM
Sensei Biotherapeutics enters at-the-market equity distribution agreement for up to $150 million stock sale
- StockTitan · Jun 14 at 11:10 PM
Sensei Biotherapeutics Announces Name Change to Faeth Therapeutics, Focused on Advancing PIKTOR, an Oral Therapy Targeting One of the Most Frequently Altered Pathways in Cancer | FTH Stock News
- rttnews · Jun 14 at 09:09 PM
Top Biotech Gainers: SNSE Awaits Data In 2H, STTK To Begin Crohn's Trial In Q3, ALMS On Watch
- benzinga_article · Jun 11 at 06:17 AM
This Daktronics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
- StockTitan · Jun 4 at 07:00 AM
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | SNSE Stock News
- Tip Ranks · Jun 1 at 09:12 PM
Dual Insider Moves Shake Up Sensei Biotherapeutics Investor Watch
